Home > Inhibitors & Agonists > Tyrosine Kinase > RET Tyrosine Kinase (c-RET)
Cat. No. Product name CAS No.
DC10633 AD80 Featured

AD80, a multikinase inhibitor, shows strong activity against human RET, BRAF, S6K, and SRC but were much less active than either AD57 or AD58 against mTOR. The IC50 value for RET is 4 nM.

1384071-99-1
DC10058 BBT594

BBT594 (NVP-BBT594), is potent and selective inhibitor of RET and JAK2.

882405-89-2
DC11479 BLU-667 (Pralsetinib) Featured

BLU-667 (Pralsetinib) is a highly potent, selective, next generation RET inhibitor with IC50 of 0.3-0.4 nM for WT RET, RET mutants V804L, V804M, M918T and CCDC6-RET fusion.

2097132-94-8
DC10936 GSK3179106 Featured

GSK3179106 (GSK-3179106, GSK 3179106) is a potent, selective, first-in-class and gut-restricted with IC50 of 0.4 and 11 nM in the biochemical assay and cellular assay respectively.

1627856-64-7
DC7763 NVP-AST487 Featured

AST 487 is a RET kinase inhibitor with IC50 of 880 nM, inhibits RET autophosphorylation and activation of downstream effectors, also inhibits Flt-3 with IC50 of 520 nM.

630124-46-8
DC11450 Selpercatinib(LOXO-292) Featured

Selpercatinib is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 163, has an IC50 of 14.0 nM, 24.1 nM, and 530.7 nM for RET (WT), RET (V804M) , and RET (G810R), respectively. Antineoplastic activity.

2152628-33-4
DC40625 WF-47-JS03

WF-47-JS03 is a potent and selective RET kinase inhibitor with IC50s of 1.7 nM and 5.3 nM for KIF5B-RET transfected Ba/F3 cells and CCDC6-RET transfected LC-2/ad lung cancer cells, respectively. WF-47-JS03 demonstrates >500-fold selectivity against kinase insert domain receptor (KDR). Effective brain penetration.

DC40626 RET-IN-3

RET-IN-3 (compound 34) is a selective RETV804M kinase inhibitor, with an IC50 of 19 nM.

2414374-53-9
DC40968 RET V804M-IN-1

RET V804M-IN-1 (compound 5) is a wt-RET -selective inhibitors of RETV804M kinase, with an IC50 of 20 nM.

2414909-94-5
Page 1 / Total 1 FirstPrevNextLastGoto